Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

EPDS can cause recurring scalp sores and hair loss if not treated.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Higher doses of isotretinoin may lead to more hair loss.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A woman with vitiligo had a rare fungal infection around her vitiligo patch and it improved with antifungal cream.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

About 61% of women who had COVID-19 experienced hair loss afterward.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

An old recipe called "Champigny Saumure" might help treat a rare scalp condition.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Topical minoxidil showed promise for early male pattern baldness.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.